Tethys Bioscience, Inc. is Granted New York State Laboratory Permit for PreDx(R) Diabetes Risk Score  
10/10/2011 10:49:07 AM

EMERYVILLE, Calif.--(BUSINESS WIRE)--Tethys Bioscience announced today that the New York State Department of Health has granted a Clinical Laboratory Permit to the CLIA-certified Tethys Clinical Laboratory (TCL) approving use of the PreDx® Diabetes Risk Score (DRS) test on samples obtained from state residents. New York’s clinical laboratory evaluation and validation process is designed to ensure the accuracy and reliability of laboratory results and compliance with departmental regulations and standards, and is considered to be the most thorough and rigorous laboratory review process in the country. Allowance of the permit provides important validation for the quality and reliability of operations at the Tethys Clinical Laboratory.